Preslaski 2012.
Methods | Randomized, double‐blind study Setting: Country: USA Period: |
Participants |
Sample size: 23 (11/12) Included Excluded Missing |
Interventions |
Interventions: add dexmedetomidine to existing benzodiazepine sedation when patients qualified for daily awakenings Control: add midazolam to existing benzodiazepine sedation |
Outcomes |
Primary
Secondary
Measured by: ICU Delirium Screening Checklist Adverse events: including haemodynamic profiles and delirium |
Notes |
Conclusion: need full paper review, but apparently delirium was monitored as an adverse event (ICU Delirium Screening Checklist) Authors have been contacted by email 19 September 2016 — awaiting response. |